Healthcare >> CEO Interviews >> June 2, 2003
DR. ARTHUR T. SANDS co-founded Lexicon Genetics Incorporated and
has been President and Chief Executive Officer and a Director
since September 1995. From 1992 to September 1995, Dr. Sands
served as an American Cancer Society postdoctoral fellow in the
Department of Human and Molecular Genetics at Baylor College of
Medicine, where he studied the function of the p53 gene in cancer
formation and created the XPC knockout mouse, a model for skin
cancer. He received his BA in Economics and Political Science
from Yale University and his MD and PhD from Baylor College of
Medicine. Profile
the technology at Lexicon Genetics?
Dr. Sands: Lexicon Genetics is a drug discovery company that is
fueled by a breakthrough
